Nestle Health Science
https://www.nestlehealthscience.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nestle Health Science
Nektar/BMS’s IL-2 Inhibitor Melanoma Failure Leaves Room For Other Contenders
Nektar is hoping the combination of bempegaldesleukin and Opdivo could have better chances in kidney and bladder cancers, but analysts aren’t sure and see other IL-2 therapeutics as having better prospects.
Aceto’s Biotron Labs Acquisition Latest Thrust In Wave Of VMS Sector Investment During Pandemic
Not only are larger firms acquiring smaller competitors or expanding portfolios by adding brands, private equity and venture capital groups accelerate buying into sector. The latest is New Mountain Capital-owned Aceto acquiring Biotron Laboratories and its Talus Mineral business.
Studies On Treating COVID-19 Inflammation And Migraines Also Weigh Efficacy Of Remote Trials
Preliminary data from Cold Springs Harbor Laboratory study suggest famotidine could mitigate inflammatory symptoms of COVID-19 in adults. Research sponsored by Nestle Health Science in Canada also points to remote studies likely to continue after emerging as a pandemic innovation.
Nestle Harvests Plant-Based Protein Firm Orgain As Latest US Nutrition Business Investment
Nestle Health Science has expanded its nutritional footprint steadily since 2017 but investing in Orgain, with option to fully acquire in 2024 brings its first business working exclusively with plant-based ingredients.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
- Other Names / Subsidiaries
-
- Prometheus Laboratories, Inc., Nestle S.A., Aimmune Therapeutics, Inc.